These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8356457)

  • 1. Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis.
    Tschoepe D; Roesen P; Schwippert B; Gries FA
    Semin Thromb Hemost; 1993; 19(2):122-8. PubMed ID: 8356457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activated megakaryocyte-platelet-system in vascular disease: focus on diabetes.
    Tschoepe D
    Semin Thromb Hemost; 1995; 21(2):152-60. PubMed ID: 7660137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large platelets circulate in an activated state in diabetes mellitus.
    Tschoepe D; Roesen P; Esser J; Schwippert B; Nieuwenhuis HK; Kehrel B; Gries FA
    Semin Thromb Hemost; 1991 Oct; 17(4):433-8. PubMed ID: 1803514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand factor in diabetic angiopathy.
    Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT; Tayebjee MH; Lim HS; Lip GY
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.
    Omoto S; Nomura S; Shouzu A; Nishikawa M; Fukuhara S; Iwasaka T
    Diabetologia; 2002 Apr; 45(4):550-5. PubMed ID: 12032632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of calpain in diabetes-associated platelet hyperactivation.
    Randriamboavonjy V; Fleming I
    Adv Pharmacol; 2010; 59():235-57. PubMed ID: 20933204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Platelet aggregation inhibitors in diabetes mellitus].
    Abrahamian H
    Acta Med Austriaca; 1999; 26(5):137-41. PubMed ID: 11512189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms of macrovascular involvement in diabetic subjects].
    Capron L
    Diabete Metab; 1994 Nov; 20(3 Pt 2):357-61. PubMed ID: 7828780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease].
    Grifò G; Lo Presti R; Montana M; Canino B; Caimi G
    Recenti Prog Med; 1995 Nov; 86(11):431-6. PubMed ID: 8539474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart disease in diabetes mellitus: a challenge for early diagnosis and intervention.
    Tschoepe D; Roesen P
    Exp Clin Endocrinol Diabetes; 1998; 106(1):16-24. PubMed ID: 9516054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the use of glycoprotein IIb/IIIa antagonists--the diabetic patient.
    Meier-Ewert HK; Nesto RW
    Rev Cardiovasc Med; 2002; 3 Suppl 1():S20-7. PubMed ID: 12439433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Platelet activation marker].
    Nomura S
    Rinsho Byori; 2003 Nov; 51(11):1096-101. PubMed ID: 14679788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The physiopathological basis for hemorrheological changes in diabetes].
    Neri Serneri GG; Galanti G; Paoli G
    Ric Clin Lab; 1983; 13 Suppl 3():149-57. PubMed ID: 6369493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular growth factors and the development of macrovascular disease in diabetes mellitus.
    Koschinsky T; Bünting CE; Rütter R; Gries FA
    Diabete Metab; 1987 Jul; 13(3 Pt 2):318-25. PubMed ID: 3308559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
    Fritschi J; Christe M; Lämmle B; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Dec; 52(3):236-9. PubMed ID: 6241750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetes, coagulation and vascular events].
    Nenci GG; Paliani U
    Recenti Prog Med; 2000 Feb; 91(2):86-90. PubMed ID: 10748654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases.
    Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaliman J
    Artery; 1980; 8(1):73-9. PubMed ID: 6158934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endothelial function and the microcirculation in diabetes mellitus].
    Arosio E; Minuz P; Prior M
    Ann Ital Med Int; 1999; 14(2):106-13. PubMed ID: 10399372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
    Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
    Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.